{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:34:58Z","timestamp":1787315698253,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.diabres.2022.110073","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T03:47:51Z","timestamp":1662436071000},"page":"110073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A combination of metformin and insulin improve cardiovascular and cerebrovascular risk factors in individuals with type 1 diabetes mellitus"],"prefix":"10.1016","volume":"191","author":[{"given":"Linlin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.diabres.2022.110073_b0005","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/dme.12676","article-title":"Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison","volume":"32","author":"McKnight","year":"2015","journal-title":"Diabet Med"},{"issue":"7","key":"10.1016\/j.diabres.2022.110073_b0010","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1007\/s00125-013-2904-2","article-title":"Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?","volume":"56","author":"Cleland","year":"2013","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.diabres.2022.110073_b0015","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1464-5491.2007.02357.x","article-title":"Insulin sensitivity in Type 1 diabetic children and adolescents","volume":"25","author":"Szadkowska","year":"2008","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.diabres.2022.110073_b0020","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2337\/dc13-1634","article-title":"Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): urinary screening and baseline biochemical and cardiovascular assessments","volume":"37","author":"Marcovecchio","year":"2014","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2022.110073_b0025","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/dc15-1990","article-title":"I. Complications Trial \/Epidemiology of Diabetes, and G. Complications Study Research, Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT\/EDIC Study 30-Year Follow-up","volume":"39","author":"Diabetes","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.diabres.2022.110073_b0030","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2337\/db16-0961","article-title":"The Effect of Diabetes on Cortical Function in Stroke: Implications for Poststroke Plasticity","volume":"66","author":"Huynh","year":"2017","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.diabres.2022.110073_b0035","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S2213-8587(17)30194-8","article-title":"Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial","volume":"5","author":"Petrie","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.diabres.2022.110073_b0040","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11011-014-9632-2","article-title":"Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia","volume":"30","author":"Ashabi","year":"2015","journal-title":"Metab Brain Dis"},{"issue":"19","key":"10.1016\/j.diabres.2022.110073_b0045","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/jama.2019.3805","article-title":"Metformin in 2019","volume":"321","author":"Flory","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2022.110073_b0050","doi-asserted-by":"crossref","unstructured":"Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, et al. Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 2019,2020. 43(2): p. 487-493.","DOI":"10.2337\/dci19-0066"},{"issue":"3","key":"10.1016\/j.diabres.2022.110073_b0055","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s13300-020-00761-w","article-title":"Metformin Delays the Development of Atherosclerosis in Type 1 Diabetes Mellitus via the Methylglyoxal Pathway","volume":"11","author":"Liu","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2022.110073_b0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2019.03.006","article-title":"Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A","volume":"852","author":"Zhang","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"10.1016\/j.diabres.2022.110073_b0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-2021-3","article-title":"Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1\/RAGE\/cathespin B signaling pathway and NLRP3 inflammasome activation","volume":"10","author":"Jia","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.diabres.2022.110073_b0070","doi-asserted-by":"crossref","first-page":"1708650","DOI":"10.1155\/2018\/1708650","article-title":"Is a Combination of a GnRH Agonist and Recombinant Growth Hormone an Effective Treatment to Increase the Final Adult Height of Girls with Precocious or Early Puberty?","volume":"2018","author":"Song","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"2","key":"10.1016\/j.diabres.2022.110073_b0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpeds.2009.08.036","article-title":"Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus","volume":"156","author":"Harrington","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.diabres.2022.110073_b0080","doi-asserted-by":"crossref","first-page":"45757","DOI":"10.1038\/srep45757","article-title":"Reactive Hyperemia Index in Patients on Maintenance Hemodialysis: Cross-sectional Data from a Cohort Study","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2022.110073_b0085","article-title":"Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test","volume":"110","author":"Rodriguez-Miguelez","year":"2016","journal-title":"J Vis Exp"},{"key":"10.1016\/j.diabres.2022.110073_b0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2840-2-10","article-title":"Brachial-ankle pulse wave velocity and symptomatic cerebral infarction in patients with type 2 diabetes: a cross-sectional study","volume":"2","author":"Ogawa","year":"2003","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.diabres.2022.110073_b0095","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.medengphy.2007.04.011","article-title":"Blood flow dynamics in patient-specific cerebral aneurysm models: the relationship between wall shear stress and aneurysm area index","volume":"30","author":"Valencia","year":"2008","journal-title":"Med Eng Phys"},{"issue":"6","key":"10.1016\/j.diabres.2022.110073_b0100","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/pedi.12422","article-title":"The role of glycemia in insulin resistance in youth with type 1 and type 2 diabetes","volume":"18","author":"Chan","year":"2017","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2022.110073_b0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12933-016-0413-6","article-title":"Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study","volume":"15","author":"Ahmed","year":"2016","journal-title":"Cardiovas Diabetol"},{"key":"10.1016\/j.diabres.2022.110073_b0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2431-13-108","article-title":"Does metformin improve vascular health in children with type 1 diabetes? Protocol for a one year, double blind, randomised, placebo controlled trial","volume":"13","author":"Anderson","year":"2013","journal-title":"BMC Pediatr"},{"issue":"21","key":"10.1016\/j.diabres.2022.110073_b0115","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/heartjnl-2015-309223","article-title":"Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality","volume":"102","author":"Anderson","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.diabres.2022.110073_b0120","doi-asserted-by":"crossref","unstructured":"Anderson JJA, Couper JJ, Giles LC, Leggett CE, Gent R, Coppin B, et al. Effect of Metformin on Vascular Function in Children With Type 1 Diabetes: A 12-Month Randomized Controlled Trial. J Clin Endocrinol Metab, 2017. 102(12): p. 4448-4456.","DOI":"10.1210\/jc.2017-00781"},{"issue":"25","key":"10.1016\/j.diabres.2022.110073_b0125","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1161\/CIRCULATIONAHA.118.035525","article-title":"Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus","volume":"138","author":"Bjornstad","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.diabres.2022.110073_b0130","doi-asserted-by":"crossref","first-page":"526","DOI":"10.20452\/pamw.1925","article-title":"Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low-density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study","volume":"123","author":"Burchardt","year":"2013","journal-title":"Pol Arch Med Wewn"},{"issue":"7-8","key":"10.1016\/j.diabres.2022.110073_b0135","doi-asserted-by":"crossref","first-page":"514","DOI":"10.20452\/pamw.3527","article-title":"Association between adjunctive metformin therapy in young type 1 diabetes patients with excess body fat and reduction of carotid intima-media thickness","volume":"126","author":"Burchardt","year":"2016","journal-title":"Pol Arch Med Wewn"},{"issue":"3","key":"10.1016\/j.diabres.2022.110073_b0140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1742-7843.2009.00380.x","article-title":"The effect of metformin in overweight patients with type 1 diabetes and poor metabolic control","volume":"105","author":"Jacobsen","year":"2009","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"10","key":"10.1016\/j.diabres.2022.110073_b0145","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1464-5491.2006.01966.x","article-title":"The effect of metformin on blood glucose control in overweight patients with Type 1 diabetes","volume":"23","author":"Khan","year":"2006","journal-title":"Diabet Med"},{"issue":"10","key":"10.1016\/j.diabres.2022.110073_b0150","doi-asserted-by":"crossref","first-page":"e3363","DOI":"10.1371\/journal.pone.0003363","article-title":"Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.","volume":"3","author":"Lund","year":"2008","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.diabres.2022.110073_b0155","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1463-1326.2009.01079.x","article-title":"Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes","volume":"11","author":"Lund","year":"2009","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.diabres.2022.110073_b0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12933-018-0797-6","article-title":"Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus","volume":"17","author":"Lunder","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.diabres.2022.110073_b0165","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/pedi.12140","article-title":"Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study","volume":"16","author":"Nadeau","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.diabres.2022.110073_b0170","first-page":"152","article-title":"Effect of metformin on endothelial function in overweight adolescents with type 1 diabetes (T1D)","volume":"17","author":"Nadeau","year":"2016","journal-title":"Pediatric Diabetes"},{"key":"10.1016\/j.diabres.2022.110073_b0175","first-page":"A76","article-title":"Metformin's impact on insulin resistance (IR) and fitness in youth with type 1 diabetes (T1D)","volume":"66","author":"Nadeau","year":"2017","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2022.110073_b0180","first-page":"69","article-title":"Metformin improves vascular haemodynamic function in youth with type 1 diabetes","volume":"66","author":"Nadeau","year":"2018","journal-title":"J Invest Med"},{"key":"10.1016\/j.diabres.2022.110073_b0185","doi-asserted-by":"crossref","first-page":"A63","DOI":"10.2337\/db18-234-OR","article-title":"Metformin improves insulin resistance (IR) and vascular health in youth with type 1 diabetes (T1D)","volume":"67","author":"Nadeau","year":"2018","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2022.110073_b0190","first-page":"S354","article-title":"Metformin in type 1 diabetes: Methods and baseline characteristics of the REMOVAL trial","volume":"59","author":"Petrie","year":"2016","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.diabres.2022.110073_b0195","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/dom.12840","article-title":"Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial","volume":"19","author":"Petrie","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2022.110073_b0200","first-page":"S555","article-title":"The removal trial: Metformin reduces progression of mean carotid intima-media thickness (cIMT) in never smokers with type 1 diabetes","volume":"61","author":"Petrie","year":"2018","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.diabres.2022.110073_b0205","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/dom.12041","article-title":"Metformin improves endothelial function in type 1 diabetic subjects: A pilot, placebo-controlled randomized study","volume":"15","author":"Pitocco","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2022.110073_b0210","doi-asserted-by":"crossref","first-page":"A115","DOI":"10.2337\/db18-431-P","article-title":"Serum uromodulin (SUMOD) inversely correlates with aortic stiffness in type 1 diabetes (T1D) youth","volume":"67","author":"Wiromrat","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.110073_b0215","first-page":"108","article-title":"Effect of metformin added to insulin on glycemic control and insulin sensitivity in adolescents with type 1 diabetes: A 24-week, prospective, randomized clinical trial","volume":"9","author":"Xu","year":"2018","journal-title":"J Diab Investig"},{"issue":"11","key":"10.1016\/j.diabres.2022.110073_b0220","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.2337\/dc13-0027","article-title":"Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: a substudy of the SCOUT trial","volume":"36","author":"Ghotbi","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2022.110073_b0225","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/dom.13642","article-title":"Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease","volume":"21","author":"Charytan","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.diabres.2022.110073_b0230","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurheartj\/ehm518","article-title":"The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial","volume":"29","author":"Mellbin","year":"2008","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.diabres.2022.110073_b0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/ijs.12023","article-title":"Safety and feasibiLIty of Metformin in patients with Impaired glucose Tolerance and a recent TIA or minor ischemic stroke (LIMIT) trial - a multicenter, randomized, open-label phase II trial","volume":"10","author":"den Hertog","year":"2015","journal-title":"Int J Stroke"},{"issue":"9","key":"10.1016\/j.diabres.2022.110073_b0240","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.diabres.2022.110073_b0245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCIMAGING.112.978114","article-title":"Results from a carotid intima-media thickness trial as a decision tool for launching a large-scale morbidity and mortality trial","volume":"6","author":"Peters","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.diabres.2022.110073_b0250","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1381612822666151109111311","article-title":"Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends","volume":"22","author":"Leone","year":"2016","journal-title":"Curr Pharm Des"},{"issue":"11","key":"10.1016\/j.diabres.2022.110073_b0255","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1210\/jc.2006-0863","article-title":"Vascular endothelial and smooth muscle function relates to body mass index and glucose in obese and nonobese children","volume":"91","author":"Pe\u00f1a","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.diabres.2022.110073_b0260","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1161\/ATVBAHA.112.300934","article-title":"Nitroglycerine-induced vasodilation for assessment of vascular function: a comparison with flow-mediated vasodilation","volume":"33","author":"Maruhashi","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.diabres.2022.110073_b0265","first-page":"193","article-title":"Review of MRI-based measurements of pulse wave velocity: a biomarker of arterial stiffness","volume":"4","author":"Wentland","year":"2014","journal-title":"Cardiovasc Diagn Ther"},{"issue":"19","key":"10.1016\/j.diabres.2022.110073_b0270","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1161\/CIRCULATIONAHA.107.748574","article-title":"Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study","volume":"117","author":"Hamburg","year":"2008","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.diabres.2022.110073_b0275","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.jacc.2009.10.074","article-title":"Predicting ischemic heart disease in women: the value of endothelial function","volume":"55","author":"Lian","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.diabres.2022.110073_b0280","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd4623","article-title":"Strategies to increase nitric oxide signalling in cardiovascular disease","volume":"14","author":"Lundberg","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"9607","key":"10.1016\/j.diabres.2022.110073_b0285","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.diabres.2022.110073_b0290","doi-asserted-by":"crossref","first-page":"888","DOI":"10.2337\/diacare.28.4.888","article-title":"Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program","volume":"28","author":"Ratner","year":"2005","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2022.110073_b0295","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/14728222.12.1.91","article-title":"AMP activated protein kinase: a next generation target for total metabolic control","volume":"12","author":"Misra","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.diabres.2022.110073_b0300","unstructured":"Salazar Martin R, Carbajal Horacio A, Espeche Walter G, Aizpur\u00faa Marcelo, Maciel Pablo M, Reaven Gerald M. Identification of cardiometabolic risk: visceral adiposity index versus triglyceride\/HDL cholesterol ratio. (0002-9343)."},{"issue":"7","key":"10.1016\/j.diabres.2022.110073_b0305","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/pedi.12493","article-title":"The effect of adding metformin to insulin therapy for type 1 diabetes mellitus children: A systematic review and meta-analysis","volume":"18","author":"Al Khalifah","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.diabres.2022.110073_b0310","doi-asserted-by":"crossref","first-page":"3854071","DOI":"10.1155\/2016\/3854071","article-title":"The Effect of Metformin on Adolescents with Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"2016","author":"Liu","year":"2016","journal-title":"Int J Endocrinol"},{"issue":"2","key":"10.1016\/j.diabres.2022.110073_b0315","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1089\/dia.2014.0190","article-title":"Efficacy and safety of metformin for patients with type 1 diabetes mellitus: a meta-analysis","volume":"17","author":"Liu","year":"2015","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.diabres.2022.110073_b0320","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00125-009-1636-9","article-title":"The use of metformin in type 1 diabetes: a systematic review of efficacy","volume":"53","author":"Vella","year":"2010","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.diabres.2022.110073_b0325","doi-asserted-by":"crossref","first-page":"e2983","DOI":"10.1002\/dmrr.2983","article-title":"Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials","volume":"34","author":"Meng","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"10.1016\/j.diabres.2022.110073_b0330","doi-asserted-by":"crossref","DOI":"10.3390\/nu8120798","article-title":"Metformin Treatment and Homocysteine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"8","author":"Zhang","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.diabres.2022.110073_b0335","doi-asserted-by":"crossref","first-page":"104261","DOI":"10.1016\/j.phrs.2019.104261","article-title":"The beneficial roles of metformin on the brain with cerebral ischaemia\/reperfusion injury","volume":"146","author":"Leech","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.diabres.2022.110073_b0340","doi-asserted-by":"crossref","unstructured":"Zhao M, Li XW, Chen Z, Hao F, Tao SX, Yu HY, et al., Neuro-Protective Role of Metformin in Patients with Acute Stroke and Type 2 Diabetes Mellitus via AMPK\/Mammalian Target of Rapamycin (mTOR) Signaling Pathway and Oxidative Stress. Med Sci Monit, 2019. 25: p. 2186-2194.","DOI":"10.12659\/MSM.911250"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:25:10Z","timestamp":1759173910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722008877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":68,"alternative-id":["S0168822722008877"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110073","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A combination of metformin and insulin improve cardiovascular and cerebrovascular risk factors in individuals with type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110073"}}